Home/Filings/4/0001213900-24-056274
4//SEC Filing

Sands Lawrence M. 4

Accession 0001213900-24-056274

CIK 0001864531other

Filed

Jun 25, 8:00 PM ET

Accepted

Jun 26, 7:27 PM ET

Size

12.2 KB

Accession

0001213900-24-056274

Insider Transaction Report

Form 4
Period: 2024-06-24
Transactions
  • Other

    Series A Preferred Stock

    2024-06-24+765765 total(indirect: See footnote 1.)
    Exercise: $10.00Common Stock (382,500 underlying)
  • Other

    Series A Preferred Stock

    2024-06-24+153153 total(indirect: See footnote 6.)
    Exercise: $10.00Common Stock (76,500 underlying)
Holdings
  • Common Stock

    (indirect: See footnote 1.)
    500,000
Transactions
  • Other

    Series A Preferred Stock

    2024-06-24+765765 total(indirect: See footnote 1.)
    Exercise: $10.00Common Stock (382,500 underlying)
  • Other

    Series A Preferred Stock

    2024-06-24+153153 total(indirect: See footnote 6.)
    Exercise: $10.00Common Stock (76,500 underlying)
Holdings
  • Common Stock

    (indirect: See footnote 1.)
    500,000
Footnotes (6)
  • [F1]Shares held by SCS Capital Partners, LLC ("SCS Capital") of which Reporting Person is the sole manager and sole member. As such, he has sole voting and investment power with respect to Issuer's securities held by SCS Capital. Mr. Sands disclaims beneficial ownership of such securities other than to the extent of his pecuniary interest, if any, therein, directly or indirectly.
  • [F2]Shares of Series A preferred stock ("Series A Stock") acquired in connection with closing of the Business Combination pursuant to the terms of the Business Combination Agreement by and among Digital Health Acquisition Corp. ("DHAC"), Digital Health Merger Sub I, Inc., Digital Health Merger Sub II, Inc., VSee Lab, Inc. and iDoc Virtual Telehealth Solutions, Inc. (iDoc") (the "Business Combination"). In the Business Combination certain indebtedness owed by DHAC to affiliates of DHAC, among others, was converted to Series A Stock.
  • [F3]The Series A Stock is convertible into Issuer's common stock at any time following the earlier of 12 months after the initial issuance of Series A Stock or the date on which no shares of Series A Stock remain outstanding.
  • [F4]Not applicable.
  • [F5]Maximum number of shares issuable.
  • [F6]Shares held by SCS, LLC of which Reporting Person is the sole manager and sole member. As such, he has sole voting and investment power with respect to Issuer's securities held by SCS, LLC. Mr. Sands disclaims beneficial ownership of such securities other than to the extent of his pecuniary interest, if any, therein, directly or indirectly.

Issuer

VSEE HEALTH, INC.

CIK 0001864531

Entity typeother

Related Parties

1
  • filerCIK 0001506824

Filing Metadata

Form type
4
Filed
Jun 25, 8:00 PM ET
Accepted
Jun 26, 7:27 PM ET
Size
12.2 KB